Vasopressin injection - Par Pharmaceutical CompaniesAlternative Names: Vasostrict
Latest Information Update: 29 Jun 2016
At a glance
- Originator Par Pharmaceutical Companies
- Class Antidiuretics; Antihaemorrhagics; Basic amino acids; Diamino amino acids; Hormones; Vasoconstrictors; Vasopressins
- Mechanism of Action Vasopressin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypotension